title: South Asian consensus guideline: Use of GLP-1 receptor agonists during Ramadan: Update 2016 Revised Guidelines on the use of GLP-1A in Ramadan.
abstract: This guidance is an update to the South Asian Consensus Guideline: Use of GLP1RA in Diabetes during Ramadan, published in the Indian Journal of Endocrinology and Metabolism in 2012. A five country working group has collated evidence and experience to suggest guidelines for the safe and rational use of glucagon-like peptide1 receptor agonists during Ramadan. The suggestions contained herewith are based upon recently published evidence as well as available basic pharmacological data.
authors.affiliation: Department of Endocrinology, Bharti Hospital and BRIDE, Karnal, Haryana, India.
authors.forename: Faruque
authors.initials: F
authors.lastname: Pathan
authors.affiliation: Director, BIRDEM, Dhaka, Bangladesh.
authors.forename: Zafar Ahmed
authors.initials: ZA
authors.lastname: Latif
authors.affiliation: Osmania Medical College, Hyderabad, India.
authors.forename: Rakesh Kumar
authors.initials: RK
authors.lastname: Sahay
authors.affiliation: Advanced Center for Diabetes and Endocrine Care, Srinagar, India.
authors.forename: Abdul Hamid
authors.initials: AH
authors.lastname: Zargar
authors.affiliation: Shaukhat Khanum Cancer Hospital and Research Center, Lahore, Pakistan.
authors.forename: Syed Abbas
authors.initials: SA
authors.lastname: Raza
authors.affiliation: Diabetes Association of Bangladesh.
authors.forename: Azad
authors.initials: A
authors.lastname: Khan
authors.affiliation: Mymensingh Medical College, Mymensingh, Bangladesh.
authors.forename: Nazrul Islam
authors.initials: NI
authors.lastname: Siddiqui
authors.affiliation: Mymensingh Medical College, Mymensingh, Bangladesh.
authors.forename: Feroz
authors.initials: F
authors.lastname: Amin
authors.affiliation: Diabetes and Endocrine Unit, National Hospital, Colombo, Sri Lanka.
authors.forename: Noel
authors.initials: N
authors.lastname: Somasundaram
authors.affiliation: Department of Endocrinology, Norvic International Hospital, Kathmandu, Nepal.
authors.forename: Dina
authors.initials: D
authors.lastname: Shrestha
authors.affiliation: Department of Endocrinology, Bharti Hospital and BRIDE, Karnal, Haryana, India.
authors.forename: Sanjay
authors.initials: S
authors.lastname: Kalra
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005215:Fasting; D052216:Glucagon-Like Peptide 1 / Q000627:therapeutic use*; D000067757:Glucagon-Like Peptide-1 Receptor; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007514:Islam; D000069450:Liraglutide; D010446:Peptide Fragments / Q000627:therapeutic use*; D010455:Peptides; D017410:Practice Guidelines as Topic; D014688:Venoms
chemical_list: D000067757:Glucagon-Like Peptide-1 Receptor; D007004:Hypoglycemic Agents; D010446:Peptide Fragments; D010455:Peptides; D014688:Venoms; C055453:glucagon-like peptide 1 (7-36)amide; D000069450:Liraglutide; D052216:Glucagon-Like Peptide 1
keywords: Dulaglutide, Exenatide QW, GLP1RA, Hypoglycaemia, Liraglutide, Lixisenatide, Ramadan, South Asia.